Author:
Huynh Huu H.,Pressiat Claire,Sauvageon Hélène,Madelaine Isabelle,Maslanka Patricia,Lebbé Céleste,Thieblemont Catherine,Goldwirt Lauriane,Mourah Samia
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Pharmacology
Reference54 articles.
1. Targeted cancer therapy;Sawyers;Nature,2004
2. Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC/MS/MS;Andriamanana;J Chromatogr B Analyt Technol Biomed Life Sci.,2013
3. Review of therapeutic drug monitoring of anticancer drugs part two–targeted therapies;Widmer;Eur J Cancer.,2014
4. Moving towards dose individualization of tyrosine kinase inhibitors;Klümpen;Cancer Treat Rev.,2011
5. Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results;Hughes;Blood,2006
Cited by
76 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献